Fox Chase Cancer Center Welcomes Michael Jay Styler

PHILADELPHIA (September 13, 2019) – Fox Chase Cancer Center announces the hiring of Michael Jay Styler, MD, who will join the Department of Hematology/Oncology as an associate professor in the academic clinician track as part of the Bone Marrow Transplant Program.

Styler comes to Fox Chase from Hahnemann University Hospital, where he served as medical director of the transplant center, apheresis center, and collection center. He was also the medical director of the stem cell transplant program and the clinical service chief of hematology/oncology.

While at Hahnemann, Styler was also an associate professor at Drexel University College of Medicine, where he served as division director of hematology/oncology and associate fellowship director of the hematology/oncology program.

He received his medical degree from the Medical College of Wisconsin. Styler completed both his residency and his hematology/oncology fellowship at Hahnemann. He is board certified in internal medicine, with subspecialties in hematology and medical oncology.

He has been published in several medical journals, given multiple poster presentations, and co-authored two book chapters. Styler started working at Fox Chase on September 9, 2019.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text